ACTINIUM PHARMACEUTICALS, INC. Derivative Liability, Current
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Derivative Liability, Current of $15.92 thousand as of 2019-12-31, per its 10-K filed 2020-05-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2020-05-08
- 2019-12-31: Derivative Liability, Current $15.92K.
- 2018-03-31: Derivative Liability, Current $6.84K.
- 2017-12-31: Derivative Liability, Current $15.92K.
- 2017-09-30: Derivative Liability, Current $54.33K.
| Period end | Derivative Liability, Current |
|---|---|
| 2019-12-31 | $15.92K 10-K · filed 2020-05-08 |
| 2018-03-31 | $6.84K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $15.92K 10-K · filed 2019-03-15 |
| 2017-09-30 | $54.33K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $426.44K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $576.03K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $300.68K 10-K · filed 2018-03-16 |
| 2016-09-30 | $431.81K 10-Q · filed 2016-10-28 |
| 2016-06-30 | $934.59K 10-Q · filed 2016-07-29 |
| 2016-03-31 | $1.23M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $2.85M 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.23M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $1.92M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $1.86M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $6.71M 10-K · filed 2016-03-11 |
| 2014-09-30 | $8.22M 10-Q · filed 2014-10-31 |
| 2014-06-30 | $9.83M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $19.13M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $6.71M 10-K · filed 2015-03-16 |
| 2013-09-30 | $2.76M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $2.96M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $2.24M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $3.57M 10-K · filed 2014-02-28 |
| 2011-12-31 | $4.44M 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |